Inside the animal lab at the Melfort Research Station; from left to right: Harry Tkachuk, Morris Hiltz, the other person is unknown at this time.

Elevated view looking northeast at National Research Council building, with Engineering Building in background.

Bio/Historical Note: In 1916 the National Research Council legislation was enacted and the institution was formed with the mandate to advise the government on matters of science and industrial research. For the first 15 or 16 years of its existence the NRC consisted of offices and borrowed lab space. It launched Canada’s first research journal, “Canadian Journal of Research” and funded research for human and bovine tuberculosis – a significant domestic problem in the 1920s. In 1932, NRC’s first dedicated lab was built in Ottawa. The NRC established a laboratory on the east side of the University of Saskatchewan campus in 1948. The original purpose of the facility was to “use chemistry and biology to diversify Canadian agriculture.” Originally called the “Prairie Regional Lab” then the “Plant Biotechnology Institute,” the facility is now known as “NRC Saskatoon.”

M. Siddigueullab and W.W. Cram investigating the chemistry of natural products.

Robert (Bob) Teed operating Kjeldahl nitrogen analysis apparatus at the Cereal Chemistry Research Lab. The first stage of the two-step process shown entailed the boiling of concentrated sulfuric acid.

Bio/Historical Note: Robert Gordon Teed was born in Humboldt on 21 Dec.1924, He moved to Saskatoon and graduated from Nutana Collegiate. He joined the Royal Canadian Army in 1943, serving overseas from 1944 until July 1946, the last year as part of the Army of Occupation. In 1947 Teed joined the Department of Chemistry, where he worked as a technician until sickness forced him to retire. Teed died on 29 Dec. 1985 in Saskatoon.

T.C. Douglas, Premier of Saskatchewan, cuts the ribbon at the opening of the Saskatchewan Cancer and Medical Research Institute.

Bio/Historical Note: The Saskatchewan Cancer and Medical Research Institute was officially opened on 10 May 1958 by Premier T.C. Douglas. Clad in locally quarried greystone with limestone panels, it was the.last of the buildings that constituted the University’s Medical Complex’s initial phase. Designed by Izumi, Arnott and Sugiyama and completed at a cost of $783,000, the building’s purpose was to provide shared accommodation for both general medical research and cancer specific investigations. Funding came from the federal and provincial governments and the provincial and national branches of the Canadian Cancer Society. A planned third floor was added in 1966. The building was "deconstructed" in 2009, with much of the building's material recycled including the greystone cladding for use with the E Wing that opened in 2013.

Unidentified speaker at the opening of the Saskatchewan Cancer and Medical Research Institute. Crowd in foreground and platform of dignitaries in background. View from behind the crowd looking towards the platform.

Bio/Historical Note: The Saskatchewan Cancer and Medical Research Institute was officially opened on 10 May 1958 by Premier T.C. Douglas. Clad in locally quarried greystone with limestone panels, it was the.last of the buildings that constituted the University’s Medical Complex’s initial phase. Designed by Izumi, Arnott and Sugiyama and completed at a cost of $783,000, the building’s purpose was to provide shared accommodation for both general medical research and cancer specific investigations. Funding came from the federal and provincial governments and the provincial and national branches of the Canadian Cancer Society. A planned third floor was added in 1966. The building was "deconstructed" in 2009, with much of the building's material recycled including the greystone cladding for use with the E Wing that opened in 2013.

The Science Service Laboratory for the Department of Agriculture. Taken from the southwest just after completion.

An empty Thorvaldson Lab.

Students at work in the Thorvaldson Laboratory.

R.W. Begg, University President, speaking from podium during an outdoor ceremony marking the opening of the Veterinary Infectious Disease Organization lab. Attendees seated behind Begg are Dr. Niels O. Nielson, dean, Western College of Veterinary Medicine; W. Weir, E. Kaeding, Dr. Chris Bigland, director of VIDO; and George Shepherd.

Bio/Historical Note: The Vaccine and Infectious Disease Organization (VIDO) is a research organization of the University of Saskatchewan that operates with financial support from the Government of Canada, the government of Saskatchewan, livestock industry councils and agencies, foundations and human and animal health companies. VIDO worked to find cures for common infectious diseases in cattle, swine and poultry. VIDO scientists carved out an international reputation for their pioneering work in the 1980's on vaccines aimed at combating shipping fever and a disease which produces pneumonia and arthritis in cattle. In addition to the 2,500,000 sq ft facility on campus, VIDO-InterVac also operates a 160-acre research station. The laboratory took on its current name, International Vaccine Centre (VIDO-InterVac), in March 2003. In October 2003 a large expansion was completed. In March 2004, VIDO received funding for the construction one of the world's largest and most advanced biosafety level 3 facilities, the International Vaccine Centre (InterVac), for research into emerging and reemerging human and animal diseases. In 2020, VIDO-InterVac began developing a vaccine for SARS-CoV-2 during the COVID-19 pandemic.

Touring the Vaccine and Infectious Disease Organization (VIDO) facilities are (l to r): R.W. Begg, University President; Dr. Christopher H. Bigland, director of VIDO; and Allan Blakeney, Premier of Saskatchewan.

Bio/Historical Note: The Vaccine and Infectious Disease Organization (VIDO) is a research organization of the University of Saskatchewan that operates with financial support from the Government of Canada, the government of Saskatchewan, livestock industry councils and agencies, foundations and human and animal health companies. VIDO worked to find cures for common infectious diseases in cattle, swine and poultry. VIDO scientists carved out an international reputation for their pioneering work in the 1980's on vaccines aimed at combating shipping fever and a disease which produces pneumonia and arthritis in cattle. In addition to the 2,500,000 sq ft facility on campus, VIDO-InterVac also operates a 160-acre research station. The laboratory took on its current name, International Vaccine Centre (VIDO-InterVac), in March 2003. In October 2003 a large expansion was completed. In March 2004, VIDO received funding for the construction one of the world's largest and most advanced biosafety level 3 facilities, the International Vaccine Centre (InterVac), for research into emerging and reemerging human and animal diseases. In 2020, VIDO-InterVac began developing a vaccine for SARS-CoV-2 during the COVID-19 pandemic.

Two people perform an operation on a cat.

Unidentified women dressed in lab coat works with mice. Her hands are in gloves that are built into a plastic enclosure.